Volgen
Linda JW Bosch
Linda JW Bosch
Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands
Geverifieerd e-mailadres voor nki.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 …
EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ...
The Lancet Oncology 20 (7), 948-960, 2019
2372019
Molecular tests for colorectal cancer screening
LJW Bosch, B Carvalho, RJA Fijneman, CR Jimenez, HM Pinedo, ...
Clinical colorectal cancer 10 (1), 8-23, 2011
1332011
Genomic landscape of metastatic colorectal cancer
JC Haan, M Labots, C Rausch, M Koopman, J Tol, LJM Mekenkamp, ...
Nature communications 5 (1), 1-12, 2014
662014
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
EMV De Cuba, R Kwakman, M Van Egmond, LJW Bosch, HJ Bonjer, ...
Virchows Archiv 461 (3), 231-243, 2012
652012
Promoter CpG island hypermethylation-and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without …
S Derks, LJW Bosch, HEC Niessen, PTM Moerkerk, SM Van Den Bosch, ...
Carcinogenesis 30 (6), 1041-1048, 2009
642009
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT
LJW Bosch, FA Oort, M Neerincx, CAJ Khalid-de Bakker, JST sive Droste, ...
Cancer Prevention Research 5 (3), 464-472, 2012
602012
Consensus molecular subtype classification of colorectal adenomas
MA Komor, LJW Bosch, G Bounova, AS Bolijn, PM Delis‐van Diemen, ...
The Journal of pathology 246 (3), 266-276, 2018
452018
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
EMV De Cuba, P Snaebjornsson, DAM Heideman, NCT Van Grieken, ...
International journal of cancer 138 (5), 1139-1145, 2016
442016
Multitarget stool DNA test performance in an average-risk colorectal cancer screening population
LJW Bosch, V Melotte, S Mongera, KLJ Daenen, VMH Coupé, ...
The American journal of gastroenterology 114 (12), 1909, 2019
402019
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer
A Jacobsen, LJW Bosch, SR Martens-de Kemp, B Carvalho, ...
Scientific reports 8 (1), 1-11, 2018
392018
Fecal tests: from blood to molecular markers
GP Young, LJW Bosch
Current colorectal cancer reports 7 (1), 62-70, 2011
352011
Novel stool-based protein biomarkers for improved colorectal cancer screening: a case–control study
LJW Bosch, M De Wit, TV Pham, VMH Coupé, AC Hiemstra, SR Piersma, ...
Annals of Internal Medicine 167 (12), 855-866, 2017
322017
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection
LJW Bosch, S Mongera, FA Oort, ST van Turenhout, MT Penning, ...
Cellular oncology 35 (4), 309-315, 2012
282012
Cost-effectiveness of high-performance biomarker tests vs fecal immunochemical test for noninvasive colorectal cancer screening
I Lansdorp-Vogelaar, SL Goede, LJW Bosch, V Melotte, B Carvalho, ...
Clinical gastroenterology and hepatology 16 (4), 504-512. e11, 2018
272018
Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression
MA Komor, LJW Bosch, VMH Coupé, C Rausch, TV Pham, SR Piersma, ...
The Journal of pathology 250 (3), 288-298, 2020
202020
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
KG Samsom, LJW Bosch, LJ Schipper, P Roepman, E de Bruijn, LR Hoes, ...
BMC medical genomics 13 (1), 1-7, 2020
162020
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
SJ Schraa, KL Van Rooijen, DEW Van Der Kruijssen, C Rubio Alarcón, ...
BMC cancer 20 (1), 1-10, 2020
162020
Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPK
D Fontijn, LJW Bosch, MCA Duyndam, MPA van Berkel, ML Janmaat, ...
Analytical Cellular Pathology 31 (3), 179-190, 2009
16*2009
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
LJW Bosch, G Trooskens, P Snaebjornsson, VMH Coupé, S Mongera, ...
Oncotarget 8 (38), 63140, 2017
132017
Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) AdenomasCancer-Associated DNA Copy Numbers in Colorectal Adenomas
B Carvalho, B Diosdado, JS Terhaar Sive Droste, AS Bolijn, MA Komor, ...
Cancer Prevention Research 11 (7), 403-412, 2018
112018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20